Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer. It develops EDAPT, a differentiated technology platform designed to explore the new and expanding Dark Antigen repertoire and to identify and assess its tumor specificity and immunogenic potential to combat cancers.
|Employees (est.) (Sept 2021)||42||(+8%)|
Enara Bio total Funding
Enara Bio latest funding size
Time since last funding
|2 years ago|
Enara Bio investors
|SV Health Investors|
Enara Bio has 241 Twitter Followers. The number of followers has increased 0.5% month over month and increased 11.3% quarter over quarter
When was Enara Bio founded?
Enara Bio was founded in 2016.
Who are Enara Bio key executives?
Enara Bio's key executives are Kevin Pojasek, Ray Jupp and Jonathon Dines.
How many employees does Enara Bio have?
Enara Bio has 46 employees.
Who are Enara Bio competitors?
Competitors of Enara Bio include Immunovo, Coherus BioSciences and Cleveland BioLabs.
Where is Enara Bio headquarters?
Enara Bio headquarters is located at Magdalen Centre, Robert Robinson Ave, Littlemore, Oxford.
Where are Enara Bio offices?
Enara Bio has offices in Oxford and London.
How many offices does Enara Bio have?
Enara Bio has 4 offices.
Receive alerts for 300+ data fields across thousands of companies